Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Benda

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Epilepsia|April 12, 2003
Postictal psychosis in temporal lobe epilepsyFritz Leutmezer, Ivo Podreka, Susanne Asenbaum, et al.
Journal of Biopharmaceutical Statistics|November 9, 2010
Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussionNorbert Benda, Werner Brannath, Frank Bretz, et al.
Statistics in Medicine|September 17, 2025
The Estimand Framework in Diagnostic Accuracy StudiesAlexander Fierenz, Mouna Akacha, Norbert Benda, et al.
Statistics in Medicine|November 28, 2019
Adaptive trial designs in diagnostic accuracy researchAntonia Zapf, Maria Stark, Oke Gerke, et al.
Archives of Toxicology|March 29, 2017
Time-matched analysis of DNA adduct formation and early gene expression as predictive tool for renal carcinogenesis in methylazoxymethanol acetate treated Eker ratsValentina Klaus, Heinke Bastek, Katja Damme, et al.
Statistics in Medicine|February 20, 2025
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional HazardsFlorian Klinglmüller, Tobias Fellinger, Franz König, et al.
Statistical Methods in Medical Research|April 9, 2024
Methods for non-proportional hazards in clinical trials: A systematic reviewMaximilian Bardo, Cynthia Huber, Norbert Benda, et al.
Pharmaceutical Statistics|November 21, 2018
On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapiesSteffen Unkel, Marjan Amiri, Norbert Benda, et al.
BMC Family Practice|April 27, 2016
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trialJulia Carolin Stingl, Katharina Luise Kaumanns, Katrin Claus, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19Nigel Stallard, Lisa Hampson, Norbert Benda, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Epilepsia|April 12, 2003
Postictal psychosis in temporal lobe epilepsyFritz Leutmezer, Ivo Podreka, Susanne Asenbaum, et al.
Journal of Biopharmaceutical Statistics|November 9, 2010
Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussionNorbert Benda, Werner Brannath, Frank Bretz, et al.
Statistics in Medicine|September 17, 2025
The Estimand Framework in Diagnostic Accuracy StudiesAlexander Fierenz, Mouna Akacha, Norbert Benda, et al.
Statistics in Medicine|November 28, 2019
Adaptive trial designs in diagnostic accuracy researchAntonia Zapf, Maria Stark, Oke Gerke, et al.
Archives of Toxicology|March 29, 2017
Time-matched analysis of DNA adduct formation and early gene expression as predictive tool for renal carcinogenesis in methylazoxymethanol acetate treated Eker ratsValentina Klaus, Heinke Bastek, Katja Damme, et al.
Statistics in Medicine|February 20, 2025
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional HazardsFlorian Klinglmüller, Tobias Fellinger, Franz König, et al.
Statistical Methods in Medical Research|April 9, 2024
Methods for non-proportional hazards in clinical trials: A systematic reviewMaximilian Bardo, Cynthia Huber, Norbert Benda, et al.
Pharmaceutical Statistics|November 21, 2018
On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapiesSteffen Unkel, Marjan Amiri, Norbert Benda, et al.
BMC Family Practice|April 27, 2016
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trialJulia Carolin Stingl, Katharina Luise Kaumanns, Katrin Claus, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19Nigel Stallard, Lisa Hampson, Norbert Benda, et al.
Pageof 5